| 摘要 |
PCT No. PCT/FR96/00991 Sec. 371 Date Jan. 29, 1999 Sec. 102(e) Date Jan. 29, 1997 PCT Filed Jun. 25, 1996 PCT Pub. No. WO97/01343 PCT Pub. Date Jan. 16, 1997This invention relates to a new use of a sophorolipidic compound, of pharmaceutically acceptable salts of the acidic form of the sophorolipid, and of the ester of the deacetylated sophorolipidic acid form as therapeutically active substances in a method for therapeutic treatment of the human or animal body, and more particularly as an activator of macrophages, as a fibrinolytic agent, as a healing agent, as a desquamating agent, and as a depigmenting agent. |
